ACE — Ascelia Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK459.60m
- SEK438.81m
Annual cashflow statement for Ascelia Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.6 | -93.4 | -138 | -147 | -111 |
| Non-Cash Items | 1.55 | 8.74 | 6.96 | 2.72 | 3.6 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.67 | -0.842 | 14.4 | 19 | -19.5 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -30.3 | -85.5 | -117 | -125 | -127 |
| Capital Expenditures | — | -0.397 | -0.038 | -0.065 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -75 | 76.4 | 0 | — | 0.047 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -75 | 76 | -0.038 | -0.065 | 0.047 |
| Financing Cash Flow Items | -21.8 | -5.29 | -13.3 | -0.084 | -0.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 200 | 92.7 | 185 | -1.1 | -0.936 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 94.9 | 76.2 | 76.9 | -112 | -128 |